Which immunodeficiency disorders are associated with hepatosplenomegaly, mild recurrent infections, and bone marrow suppression?

Hemophagocytic Syndromes and Disorders of Immune Dysregulation

The immunodeficiency disorders most characteristically associated with hepatosplenomegaly, mild recurrent infections, and bone marrow suppression are the hemophagocytic syndromes and disorders of immune dysregulation, particularly hemophagocytic lymphohistiocytosis (HLH) and related conditions. 1

Primary Differential Diagnosis

Hemophagocytic Syndromes (Most Likely)

The hemophagocytic syndromes represent the classic presentation matching this triad 1:

• Presentation: Often triggered by viral infections with fulminant acute onset
• Key features: Hepatosplenomegaly, fever, pancytopenia (bone marrow suppression)
• Infection pattern: Recurrent infections due to immune dysregulation
• Pathophysiology: Widespread organ infiltration with mononucleated cells

Critical management point: These patients require aggressive chemotherapy followed by hematopoietic stem cell transplantation (HSCT) to prevent immediate fatality 1.

Deficiency of Adenosine Deaminase 2 (DADA2)

This represents a more recently characterized entity that precisely matches your clinical triad 2:

• Hematologic manifestations: Pure red cell aplasia or bone marrow failure (BMF) syndrome
• Common features: Recurrent infections, hepatosplenomegaly, gingivitis
• Infection severity: Half of BMF patients died from infection in reported series
• Key distinction: Unlike vasculitis-predominant DADA2, these patients are largely refractory to TNF inhibitors

Genotype-phenotype correlation: Complete or near-complete loss of ADA2 enzymatic function (nonsense variants, insertions/deletions) associates with bone marrow failure, whereas partial function loss (≥3% residual activity) associates with vasculitis 2.

Chediak-Higashi Syndrome (Accelerated Phase)

This phagocytic defect can present with the described triad 3:

• Baseline features: Large inclusion bodies in leukocytes, albinism, photophobia, nystagmus
• Accelerated phase: Hepatosplenomegaly, lymphadenopathy, pancytopenia, fever
• Pathology: Widespread organ infiltrates with mononucleated cells
• Prognosis: Uniformly fatal without bone marrow transplantation

Less Likely but Important Considerations

Combined Immunodeficiencies with Syndromic Features

Several syndromic immunodeficiencies can present with hepatosplenomegaly 1:

• Wiskott-Aldrich syndrome
• Ataxia-telangiectasia
• Hyper-IgE syndromes

However, these typically present with more severe infections rather than "mild recurrent infections," making them less consistent with your clinical picture.

Omenn Syndrome (Severe Combined Immunodeficiency with Hypereosinophilia)

This presents with 4:

• Hepatosplenomegaly, polyadenopathy
• Severe and repeated infections (not mild)
• Marked eosinophilia
• Uniformly fatal within first year without treatment

Key distinction: The severity of infections in Omenn syndrome exceeds "mild recurrent infections."

Diagnostic Approach

Initial laboratory evaluation should include:

1. Complete blood count with differential: Look for pancytopenia, eosinophilia
2. Ferritin, triglycerides, fibrinogen: Markedly elevated ferritin and triglycerides with low fibrinogen suggest HLH
3. NK cell function and perforin expression: Defects indicate familial HLH
4. ADA2 enzymatic activity: If available, particularly with gingivitis present
5. Bone marrow examination: Essential to document hemophagocytosis or dysplasia
6. Immunoglobulin levels and lymphocyte subsets: To characterize immune defect

Critical pitfall: Do not delay treatment for hemophagocytic syndromes while awaiting genetic confirmation. These conditions require urgent intervention to prevent mortality 1.

Management Priorities

For hemophagocytic syndromes: Immediate chemotherapy (typically HLH-94 or HLH-2004 protocols) followed by definitive HSCT 1.

For DADA2 with bone marrow failure: TNF inhibitors are typically ineffective; proceed directly to HSCT evaluation 2.

For Chediak-Higashi accelerated phase: Splenectomy may provide temporary improvement in pancytopenia, but bone marrow transplantation is necessary for definitive treatment 3.

The combination of hepatosplenomegaly with bone marrow suppression and only mild infections (rather than severe opportunistic infections) strongly suggests a disorder of immune dysregulation rather than a severe combined or predominantly antibody deficiency.